Continuous glucose monitoring (CGM) for inpatient diabetes management: an update on the current evidence and practice

Link to article at PubMed

Endocr Connect. 2023 Aug 1:EC-23-0180. doi: 10.1530/EC-23-0180. Online ahead of print.


Over the last few years, several exciting changes in continuous glucose monitoring (CGM) technology have expanded its use and made CGM the standard of care for patients with type 1 and type 2 diabetes using insulin therapy. Consequently, hospitals started to notice increased use of these devices in their hospitalized patients. Furthermore during the COVID pandemic, there was a critical need for innovative approaches to glycemic monitoring, and several hospitals started to implement CGM protocols in their daily practice. Subsequently, a plethora of studies have demostrated the efficacy and safety of CGM use in the hospital, leading to clinical practice guideline recommendations. Several studies have also suggested that CGM has the potential to become the standard of care for some hospitalized patients, overcoming the limitations of current capillary glucose testing. Albeit, there is a need for more studies, and particularly regulatory approval. In this review, we provide an historical overview of the evolution of glycemic monitoring in the hospital, and review the current evidence, implementation protocols, and guidance for the use of CGM in hospitalized patients.

PMID:37578799 | DOI:10.1530/EC-23-0180

Leave a Reply

Your email address will not be published. Required fields are marked *